Literature DB >> 16107385

Imaging in multiple sclerosis.

S A Trip1, D H Miller.   

Abstract

Entities:  

Mesh：

Year:  2005        PMID： 16107385      PMCID： PMC1765701          DOI： 10.1136/jnnp.2005.073213

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN： 0022-3050            Impact factor:   10.154


× No keyword cloud information.
  10 in total

1.  Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis.

Authors:  M Tintoré; A Rovira; M J Martínez; J Rio; P Díaz-Villoslada; L Brieva; C Borrás; E Grivé; J Capellades; X Montalban
Journal:  AJNR Am J Neuroradiol       Date:  2000-04       Impact factor: 3.825

Review 2.  The role of MRI in the diagnosis of MS.

Authors:  P M Pretorius; G Quaghebeur
Journal:  Clin Radiol       Date:  2003-06       Impact factor: 2.350

Review 3.  Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis.

Authors:  F Barkhof; M Filippi; D H Miller; P Scheltens; A Campi; C H Polman; G Comi; H J Adèr; N Losseff; J Valk
Journal:  Brain       Date:  1997-11       Impact factor: 13.501

4.  New diagnostic criteria for multiple sclerosis: guidelines for research protocols.

Authors:  C M Poser; D W Paty; L Scheinberg; W I McDonald; F A Davis; G C Ebers; K P Johnson; W A Sibley; D H Silberberg; W W Tourtellotte
Journal:  Ann Neurol       Date:  1983-03       Impact factor: 10.422

5.  A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.

Authors:  Vanda A Lennon; Dean M Wingerchuk; Thomas J Kryzer; Sean J Pittock; Claudia F Lucchinetti; Kazuo Fujihara; Ichiro Nakashima; Brian G Weinshenker
Journal:  Lancet       Date:  2004 Dec 11-17       Impact factor: 79.321

6.  Spinal-cord MRI in multiple sclerosis.

Authors:  Geert Lycklama; Alan Thompson; Massimo Filippi; David Miller; Chris Polman; Franz Fazekas; Frederik Barkhof
Journal:  Lancet Neurol       Date:  2003-09       Impact factor: 44.182

Review 7.  A review of structural magnetic resonance neuroimaging.

Authors:  M Symms; H R Jäger; K Schmierer; T A Yousry
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-09       Impact factor: 10.154

Review 8.  Clinically isolated syndromes suggestive of multiple sclerosis, part 2: non-conventional MRI, recovery processes, and management.

Authors:  David Miller; Frederik Barkhof; Xavier Montalban; Alan Thompson; Massimo Filippi
Journal:  Lancet Neurol       Date:  2005-06       Impact factor: 44.182

Review 9.  Clinically isolated syndromes suggestive of multiple sclerosis, part I: natural history, pathogenesis, diagnosis, and prognosis.

Authors:  David Miller; Frederik Barkhof; Xavier Montalban; Alan Thompson; Massimo Filippi
Journal:  Lancet Neurol       Date:  2005-05       Impact factor: 44.182

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422
  10 in total
  14 in total

1.  Macular and Retinal Nerve Fibre Layer Thinning in Xeroderma Pigmentosum: A Cross-sectional Study.

Authors:  Anna M Gruener; Ana M S Morley
Journal:  Neuroophthalmology       Date:  2018-05-22

2.  Congenital Adrenal Hyperplasia and Brain Health: A Systematic Review of Structural, Functional, and Diffusion Magnetic Resonance Imaging (MRI) Investigations.

Authors:  Noor Khalifeh; Adam Omary; Devyn L Cotter; Mimi S Kim; Mitchell E Geffner; Megan M Herting
Journal:  J Child Neurol       Date:  2022-06-23       Impact factor: 2.363

3.  1H-MRS for the diagnosis of acute disseminated encephalomyelitis: insight into the acute-disease stage.

Authors:  Liat Ben Sira; Elka Miller; Moran Artzi; Aviva Fattal-Valevski; Shlomi Constantini; Dafna Ben Bashat
Journal:  Pediatr Radiol       Date:  2009-10-22

4.  A local group differences test for subject-level multivariate density neuroimaging outcomes.

Authors:  Jordan D Dworkin; Kristin A Linn; Andrew J Solomon; Theodore D Satterthwaite; Armin Raznahan; Rohit Bakshi; Russell T Shinohara
Journal:  Biostatistics       Date:  2021-07-17       Impact factor: 5.899

5.  Development of a protocol to assess within-subject, regional white matter hyperintensity changes in aging and dementia.

Authors:  Ahmed A Bahrani; Charles D Smith; Justin M Barber; Omar M Al-Janabi; David K Powell; Anders H Andersen; Brandon D Ramey; Erin L Abner; Larry B Goldstein; Zachary Winder; Brian T Gold; Linda Van Eldik; Donna M Wilcock; Gregory A Jicha
Journal:  J Neurosci Methods       Date:  2021-06-24       Impact factor: 2.987

Review 6.  Optical Coherence Tomography in Alzheimer's Disease and Other Neurodegenerative Diseases.

Authors:  Jonah Doustar; Tania Torbati; Keith L Black; Yosef Koronyo; Maya Koronyo-Hamaoui
Journal:  Front Neurol       Date:  2017-12-19       Impact factor: 4.003

Review 7.  The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis.

Authors:  Maria A Rocca; Giancarlo Comi; Massimo Filippi
Journal:  Front Neurol       Date:  2017-09-04       Impact factor: 4.003

Review 8.  Transcranial Magnetic Stimulation as a Potential Biomarker in Multiple Sclerosis: A Systematic Review with Recommendations for Future Research.

Authors:  Nicholas J Snow; Katie P Wadden; Arthur R Chaves; Michelle Ploughman
Journal:  Neural Plast       Date:  2019-09-16       Impact factor: 3.599

9.  A phase 2 multicenter study of ublituximab, a novel glycoengineered anti-CD20 monoclonal antibody, in patients with relapsing forms of multiple sclerosis.

Authors:  Edward Fox; Amy E Lovett-Racke; Matthew Gormley; Yue Liu; Maria Petracca; Sirio Cocozza; Richard Shubin; Sibyl Wray; Michael S Weiss; Jenna A Bosco; Sean A Power; Koby Mok; Matilde Inglese
Journal:  Mult Scler       Date:  2020-04-30       Impact factor: 6.312

Review 10.  Current Methods of Magnetic Resonance for Noninvasive Assessment of Molecular Aspects of Pathoetiology in Multiple Sclerosis.

Authors:  Petra Hnilicová; Oliver Štrbák; Martin Kolisek; Egon Kurča; Kamil Zeleňák; Štefan Sivák; Ema Kantorová
Journal:  Int J Mol Sci       Date:  2020-08-25       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.